GE HealthCare Technologies (GEHC) Projected to Post Earnings on Thursday

GE HealthCare Technologies (NASDAQ:GEHC) is anticipated to release its earnings data before the market opens on Thursday, February 13th. Analysts expect GE HealthCare Technologies to post earnings of $1.26 per share and revenue of $5.33 billion for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

GE HealthCare Technologies Trading Up 0.3 %

NASDAQ GEHC opened at $87.17 on Thursday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The business has a fifty day simple moving average of $83.14 and a 200 day simple moving average of $85.15. GE HealthCare Technologies has a 12 month low of $74.51 and a 12 month high of $94.55. The firm has a market capitalization of $39.83 billion, a P/E ratio of 23.95, a PEG ratio of 2.92 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.85%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on GEHC shares. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.